REBECCA UNGER: Open Payments
NPI 1528507266 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 61 payments from 22 companies in 2025. Trend: 2023 $1,758 · 2024 $2,220 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $284 |
| UCB, Inc. | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Alexion Pharmaceuticals, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Medtronic, Inc. | 2 | $45 |
Products named: RINVOQ, Bimzelx, TREMFYA, COSENTYX, XELJANZ, SKYRIZI, SAPHNELO, KRYSTEXXA.
Industry payments across NC — which companies pay providers there.
